BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15317450)

  • 1. Determinants of retinoid X receptor transcriptional antagonism.
    Cavasotto CN; Liu G; James SY; Hobbs PD; Peterson VJ; Bhattacharya AA; Kolluri SK; Zhang XK; Leid M; Abagyan R; Liddington RC; Dawson MI
    J Med Chem; 2004 Aug; 47(18):4360-72. PubMed ID: 15317450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.
    Vu-Dac N; Gervois P; Torra IP; Fruchart JC; Kosykh V; Kooistra T; Princen HM; Dallongeville J; Staels B
    J Clin Invest; 1998 Aug; 102(3):625-32. PubMed ID: 9691099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.
    Dhar A; Liu S; Klucik J; Berlin KD; Madler MM; Lu S; Ivey RT; Zacheis D; Brown CW; Nelson EC; Birckbichler PJ; Benbrook DM
    J Med Chem; 1999 Sep; 42(18):3602-14. PubMed ID: 10479291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells.
    Boudjelal M; Voorhees JJ; Fisher GJ
    Exp Cell Res; 2002 Mar; 274(1):130-7. PubMed ID: 11855864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor specificity of retinoid-induced epidermal hyperplasia: effect of RXR-selective agonists and correlation with topical irritation.
    Thacher SM; Standeven AM; Athanikar J; Kopper S; Castilleja O; Escobar M; Beard RL; Chandraratna RA
    J Pharmacol Exp Ther; 1997 Aug; 282(2):528-34. PubMed ID: 9262312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the first retinoid X, receptor homodimer antagonist.
    Canan Koch SS; Dardashti LJ; Hebert JJ; White SK; Croston GE; Flatten KS; Heyman RA; Nadzan AM
    J Med Chem; 1996 Aug; 39(17):3229-34. PubMed ID: 8765503
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity.
    Farooqui M; Franco PJ; Thompson J; Kagechika H; Chandraratna RA; Banaszak L; Wei LN
    Biochemistry; 2003 Feb; 42(4):971-9. PubMed ID: 12549917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR; Bourguet W; Altucci L; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.
    Géhin M; Vivat V; Wurtz JM; Losson R; Chambon P; Moras D; Gronemeyer H
    Chem Biol; 1999 Aug; 6(8):519-29. PubMed ID: 10421757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity.
    Jong L; Lehmann JM; Hobbs PD; Harlev E; Huffman JC; Pfahl M; Dawson MI
    J Med Chem; 1993 Sep; 36(18):2605-13. PubMed ID: 8410972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy.
    Germain P; Iyer J; Zechel C; Gronemeyer H
    Nature; 2002 Jan; 415(6868):187-92. PubMed ID: 11805839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid receptor beta,gamma-selective ligands: synthesis and biological activity of 6-substituted 2-naphthoic acid retinoids.
    Yu KL; Spinazze P; Ostrowski J; Currier SJ; Pack EJ; Hammer L; Roalsvig T; Honeyman JA; Tortolani DR; Reczek PR; Mansuri MM; Starrett JE
    J Med Chem; 1996 Jun; 39(12):2411-21. PubMed ID: 8691435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.
    Beard RL; Chandraratna RA; Colon DF; Gillett SJ; Henry E; Marler DK; Song T; Denys L; Garst ME; Arefieg T
    J Med Chem; 1995 Jul; 38(15):2820-9. PubMed ID: 7636843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corepressor interaction differentiates the permissive and non-permissive retinoid X receptor heterodimers.
    Lammi J; Perlmann T; Aarnisalo P
    Arch Biochem Biophys; 2008 Apr; 472(2):105-14. PubMed ID: 18282463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors.
    García J; Khanwalkar H; Pereira R; Erb C; Voegel JJ; Collette P; Mauvais P; Bourguet W; Gronemeyer H; de Lera AR
    Chembiochem; 2009 May; 10(7):1252-9. PubMed ID: 19343742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.
    Dawson MI; Ye M; Cao X; Farhana L; Hu QY; Zhao Y; Xu LP; Kiselyuk A; Correa RG; Yang L; Hou T; Reed JC; Itkin-Ansari P; Levine F; Sanner MF; Fontana JA; Zhang XK
    ChemMedChem; 2009 Jul; 4(7):1106-19. PubMed ID: 19378296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
    Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
    Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonist analogue of 6-[3'-(1-adamantyl)-4'-hydroxyphenyl]-2-naphthalenecarboxylic acid (AHPN) family of apoptosis inducers that effectively blocks AHPN-induced apoptosis but not cell-cycle arrest.
    Dawson MI; Harris DL; Liu G; Hobbs PD; Lange CW; Jong L; Bruey-Sedano N; James SY; Zhang XK; Peterson VJ; Leid M; Farhana L; Rishi AK; Fontana JA
    J Med Chem; 2004 Jul; 47(14):3518-36. PubMed ID: 15214780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoid receptor subtype-selective modulators through synthetic modifications of RARgamma agonists.
    Alvarez S; Alvarez R; Khanwalkar H; Germain P; Lemaire G; Rodríguez-Barrios F; Gronemeyer H; de Lera AR
    Bioorg Med Chem; 2009 Jul; 17(13):4345-59. PubMed ID: 19482478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases.
    van Neerven S; Kampmann E; Mey J
    Prog Neurobiol; 2008 Aug; 85(4):433-51. PubMed ID: 18554773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.